Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00721695 · ClinicalTrials.gov registry record · Phase 1
Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.
A Phase 1 study of Cataract Extraction, sponsored by Omeros Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 4
- Study locations
NCT00721695: Completed Phase 1 study of Cataract Extraction, sponsored by Omeros Corporation.
NCT00721695 is a Phase 1 study of Cataract Extraction that has completed, run by Omeros Corporation. The registered enrollment target is 60 participants, below the 92-participant average among 4 other Cataract Extraction trials with a reported enrollment target (35% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00721695, a Phase 1 study of Cataract Extraction, has completed, sponsored by Omeros Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is an exploratory study to determine the safety and clinical benefit of OMS302 Injection in subjects undergoing Cataract Extraction with Lens Replacement (CELR) using a coaxial phacoemulsification process.
Conditions Studied
Interventions
- DRUG Vehicle
- DRUG OMS302
- DRUG OMS302-PE
Study Locations (4)
California
- Shasta Eye Medical Group - Redding
Minnesota
- Chu Vision Institute - Bloomington
Missouri
- Silverstein Eye Centers - Kansas City
Wisconsin
- Davis Duehr Dean - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-02 |
| Phase | Phase 1 |
What the finished NCT00721695 record still lists
NCT00721695 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 92-participant average among 4 other Cataract Extraction trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Cataract Extraction appearing as the primary indexed condition, and to 3 interventions - of which Vehicle is the first listed.
NCT00721695 reports a single indexed study location in California, Minnesota, Missouri.
Frequently Asked Questions
What is clinical trial NCT00721695 about?
NCT00721695 is a clinical study titled "Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.". This is an exploratory study to determine the safety and clinical benefit of OMS302 Injection in subjects undergoing Cataract Extraction with Lens Replacement (CELR) using a coaxial phacoemulsification process.
What is the current status of trial NCT00721695?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2008-05. Estimated completion is 2009-02.
What conditions does trial NCT00721695 study?
This clinical trial studies the following conditions: Cataract Extraction.
What interventions are being tested in trial NCT00721695?
The interventions under investigation include: Vehicle (DRUG), OMS302 (DRUG), OMS302-PE (DRUG).
Who is sponsoring clinical trial NCT00721695?
This trial is sponsored by Omeros Corporation, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00721695 being conducted?
This trial has 4 study locations across California, Minnesota, Missouri, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract Extraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Visual Outcomes and Patient Satisfaction After Cataract Surgery and Implantation of ReSTOR and ReZoom IOLs
COMPLETED · Phase 4
-
Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction
COMPLETED
-
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
COMPLETED · Phase 3
-
Study of Ocular Penetration of Topically Administered Fluoroquinolones
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia